Skip to main content
HR 5435 117th Congress House

BRAIN Act of 2021

Official title: To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence and a N… Show full official titleShow less

Official title: To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence and a Neuroscience Translation Working Group, and for other purposes.

Introduced: December 9, 2021 See on congress.gov
Health Advisory bodiesDepartment of Health and Human ServicesDrug therapyExecutive agency funding and structure
More subjectsShow fewer subjects
Food and Drug Administration (FDA)Medical researchNeurological disordersScientific communication
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 1, 2021
Referred to the Subcommittee on Health.
Sep 30, 2021
Referred to the House Committee on Energy and Commerce.
Sep 30, 2021
Sponsor introductory remarks on measure. (CR E1050)
Sep 30, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action October 1, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021

This bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence.

The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system.

The FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 5
All 5 Democratic 2 Republican 2
D
Tonko, Paul
New York · Feb 2, 2022
 D
Chu, Judy
California · Jan 20, 2022
 R
Fitzpatrick, Brian K.
Pennsylvania · Dec 9, 2021
 R
Bacon, Don
Nebraska · Sep 30, 2021
Pascrell, Bill
· Sep 30, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5435: BRAIN Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5435/
MLA
"H.R. 5435: BRAIN Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5435/.
Bluebook (legal)
H.R. 5435, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5435/.
Markdown link
[H.R. 5435: BRAIN Act of 2021](https://openamerica.io/bill/117-HR-5435/)
Report a problem